AR126259A1 - Combinación de cinamaldehído y eugenol con actividad antimicótica - Google Patents
Combinación de cinamaldehído y eugenol con actividad antimicóticaInfo
- Publication number
- AR126259A1 AR126259A1 ARP220101686A ARP220101686A AR126259A1 AR 126259 A1 AR126259 A1 AR 126259A1 AR P220101686 A ARP220101686 A AR P220101686A AR P220101686 A ARP220101686 A AR P220101686A AR 126259 A1 AR126259 A1 AR 126259A1
- Authority
- AR
- Argentina
- Prior art keywords
- combination
- eugenol
- cinnamaldehyde
- plant origin
- antifugal
- Prior art date
Links
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 title abstract 4
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 title abstract 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 title abstract 2
- 239000005770 Eugenol Substances 0.000 title abstract 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 title abstract 2
- 229940117916 cinnamic aldehyde Drugs 0.000 title abstract 2
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002217 eugenol Drugs 0.000 title abstract 2
- 230000001716 anti-fugal effect Effects 0.000 title 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007910 systemic administration Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describe una combinación de ingredientes activos de origen vegetal o análogos sintéticos o extractos de origen vegetal que contienen cinamaldehído y eugenol o derivados de los mismos, útil como antimicótico para uso terapéutico tanto en humanos como veterinario, principalmente contra infecciones fúngicas causadas por Candida, y composiciones que contienen dicha combinación para administración tópica o sistémica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102021000017054A IT202100017054A1 (it) | 2021-06-29 | 2021-06-29 | Associazione di cinnamaldeide ed eugenolo ad attività antimicotica |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR126259A1 true AR126259A1 (es) | 2023-10-04 |
Family
ID=78086641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220101686A AR126259A1 (es) | 2021-06-29 | 2022-06-28 | Combinación de cinamaldehído y eugenol con actividad antimicótica |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240197650A1 (es) |
| EP (1) | EP4362925A1 (es) |
| AR (1) | AR126259A1 (es) |
| BR (1) | BR112023025182A2 (es) |
| IT (1) | IT202100017054A1 (es) |
| WO (1) | WO2023275020A1 (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214392B2 (en) | 2003-02-25 | 2007-05-08 | Bio-Botanica, Inc. | Process and composition for inhibiting growth of microorganisms |
| WO2012114201A1 (en) | 2011-02-25 | 2012-08-30 | Aroma Technologies | Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic |
| CN105362257B (zh) * | 2015-11-10 | 2018-10-26 | 河北医科大学第二医院 | 一种用于制备抗皮肤真菌感染药物的中药提取组合物 |
-
2021
- 2021-06-29 IT IT102021000017054A patent/IT202100017054A1/it unknown
-
2022
- 2022-06-28 US US18/288,840 patent/US20240197650A1/en active Pending
- 2022-06-28 AR ARP220101686A patent/AR126259A1/es unknown
- 2022-06-28 WO PCT/EP2022/067681 patent/WO2023275020A1/en active Application Filing
- 2022-06-28 BR BR112023025182A patent/BR112023025182A2/pt unknown
- 2022-06-28 EP EP22740808.5A patent/EP4362925A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IT202100017054A1 (it) | 2022-12-29 |
| US20240197650A1 (en) | 2024-06-20 |
| EP4362925A1 (en) | 2024-05-08 |
| WO2023275020A1 (en) | 2023-01-05 |
| BR112023025182A2 (pt) | 2024-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020000798A1 (es) | Composiciones sinegísticas de pesticidas y métodos para la entrega de ingredientes activos. | |
| BR112014019262A8 (pt) | Composições orais veterinárias parasíticas compreendendo ingredientes ativos de ação sistêmica, métodos e uso das mesmas | |
| CL2015001959A1 (es) | (divisional solicitud 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos | |
| CL2011000135A1 (es) | Uso de una fromulacion farmaceutica acuosa que comprende 0,5-10% de terbinafina o una sal de la misma, 2-10% de un fosfolipido y 1-5% de un surfactante, para preparar un medicamento util para tratar una infeccion fungica; formulacion farmaceutica. | |
| CO6390034A2 (es) | Uso de una composición espumable esencialmente libre de ingredientes con actividad farmacéutica para el tratamiento de la piel humana | |
| AR046878A1 (es) | Agente endoparasiticida para administracion topica | |
| ECSP14019920A (es) | Composiciones tópicas que comprenden fipronilo y permetrina y sus métodos de uso | |
| BR112018068532A2 (pt) | combinações de inibidores de lsd1 para o tratamento de malignidades hematológicas | |
| CL2020000220A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
| CL2020002252A1 (es) | Formulación oftálmica. | |
| CL2011001017A1 (es) | Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster. | |
| AR074974A1 (es) | Una composicion ectoparasiticida topica | |
| PE20180026A1 (es) | Composicion topica curativa | |
| BR112014016661A2 (pt) | formulação de liberação prolongada para reduzir a frequência de urinação e método de uso da mesma | |
| BR112014016550A8 (pt) | formulação de liberação retardada para reduzir a frequência de urinação e método de uso da mesma | |
| ECSP10010588A (es) | Formulacion de medicamento solida con liberacion retardada | |
| CL2019003572A1 (es) | Combinaciones de brimonidina de dosis baja y usos de las mismas. | |
| CL2019002172A1 (es) | Agente terapéutico para enfermedades del hígado. | |
| CL2012002893A1 (es) | Composición de al menos un ingrediente activo de origen vegetal o sintético análogo del mismo, o extracto de origen vegetal que lo contiene, en una solución acuosa, que además comprende lecitina como agente encapsulante; medicamento que la comprende; método para su preparación; y su uso para tratar parasitosis intestinales. | |
| AR083594A1 (es) | Composiciones para el tratamiento de ulceras perifericas de varios origenes | |
| UY38982A (es) | Composiciones farmacéuticas | |
| BR112015031846A8 (pt) | derivados de estratrientiazol, seus usos, e composição farmacêutica | |
| AR052882A1 (es) | Composicion antihelmintica | |
| CL2020000221A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
| AR126259A1 (es) | Combinación de cinamaldehído y eugenol con actividad antimicótica |